| Jordan Morton, MD | |
|
920 Sl Young Blvd, Oklahoma City, OK 73104-5036 | |
| (405) 271-5635 | |
| Not Available |
| Full Name | Jordan Morton |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 13 Years |
| Location | 920 Sl Young Blvd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659665867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 28500 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Home Health | Oklahoma city, OK | Home health agency |
| Mercy Hospice | Oklahoma city, OK | Hospice |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Mercy Hospital Logan County, Inc | Guthrie, OK | Hospital |
| Mercy Hospital Ardmore, Inc | Ardmore, OK | Hospital |
| Oklahoma Heart Hospital, Llc | Oklahoma city, OK | Hospital |
| Mercy Hospital Kingfisher, Inc | Kingfisher, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Oklahoma Communities | 1153468921 | 485 |
News Archive
Media outlets analyze the data on premiums for 36 states released this week by the Obama administration - looking at the impact of competition on prices and assessing which regions - and which consumers - might be winners or losers in the new online marketplaces.
St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company's LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.
A technique that uses focused ultrasound under magnetic resonance guidance to heat and destroy tumors may offer a safe and effective treatment for breast cancer, according to research being presented today at the annual meeting of the Radiological Society of North America.
RelayHealth announced today that Catholic Health Initiatives (CHI), the nation's second-largest Catholic healthcare system, has chosen RelayHealth RevRunner to verify patient eligibility for healthcare benefits.
Thirteen pharmaceutical companies; the governments of the U.S., U.K. and United Arab Emirates; the Bill & Melinda Gates Foundation; the WHO; the World Bank; the Drugs for Neglected Diseases initiative (DNDi); and other global health organizations "announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade," according to a press release from Global Health Strategies.
› Verified 8 days ago
| Entity Name | Mercy Clinic Oklahoma Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
Media outlets analyze the data on premiums for 36 states released this week by the Obama administration - looking at the impact of competition on prices and assessing which regions - and which consumers - might be winners or losers in the new online marketplaces.
St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company's LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.
A technique that uses focused ultrasound under magnetic resonance guidance to heat and destroy tumors may offer a safe and effective treatment for breast cancer, according to research being presented today at the annual meeting of the Radiological Society of North America.
RelayHealth announced today that Catholic Health Initiatives (CHI), the nation's second-largest Catholic healthcare system, has chosen RelayHealth RevRunner to verify patient eligibility for healthcare benefits.
Thirteen pharmaceutical companies; the governments of the U.S., U.K. and United Arab Emirates; the Bill & Melinda Gates Foundation; the WHO; the World Bank; the Drugs for Neglected Diseases initiative (DNDi); and other global health organizations "announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade," according to a press release from Global Health Strategies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Morton, MD 920 Sl Young Blvd, Oklahoma City, OK 73104-5036 Ph: (405) 271-5963 | Jordan Morton, MD 920 Sl Young Blvd, Oklahoma City, OK 73104-5036 Ph: (405) 271-5635 |
News Archive
Media outlets analyze the data on premiums for 36 states released this week by the Obama administration - looking at the impact of competition on prices and assessing which regions - and which consumers - might be winners or losers in the new online marketplaces.
St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company's LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.
A technique that uses focused ultrasound under magnetic resonance guidance to heat and destroy tumors may offer a safe and effective treatment for breast cancer, according to research being presented today at the annual meeting of the Radiological Society of North America.
RelayHealth announced today that Catholic Health Initiatives (CHI), the nation's second-largest Catholic healthcare system, has chosen RelayHealth RevRunner to verify patient eligibility for healthcare benefits.
Thirteen pharmaceutical companies; the governments of the U.S., U.K. and United Arab Emirates; the Bill & Melinda Gates Foundation; the WHO; the World Bank; the Drugs for Neglected Diseases initiative (DNDi); and other global health organizations "announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade," according to a press release from Global Health Strategies.
› Verified 8 days ago
Evelyn Lorents, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |